Atlas Trials

SHR-1701 With or Without Apatinib in Combination With Chemotherapy as Neoadjuvant Therapy for Gastric Cancer

Clinical trial NCT07464756 · RECRUITING

Trial details

NCT number
NCT07464756
Sponsor
The First Affiliated Hospital with Nanjing Medical University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Gastric Adenocarcinoma
Start date
2026-04-03
Primary completion
2028-05-31
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.